حدد سهمًا أو عملة مشفرة في شريط البحث للحصول على ملخص
Piramal Pharma Limited
PPLPHARMAPiramal Pharma Limited operates as a pharmaceutical company in North America, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the spectrum of the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; complex hospital generics business which offers inhalation anesthetics, intrathecal therapy for spasticity management, injectable pain and anesthesia drugs, and other generic and specialty products; and India consumer healthcare business comprising analgesics, skin care, vitamin/mineral supplement, kids' wellness, digestives, women's health, and hygiene and protection. The company was incorporated in 2020 and is based in Mumbai, India. Address: Piramal Ananta, Mumbai, India, 400 070
Analytics
سعر الهدف في وول ستريت
–نسبة السعر إلى الأرباح
704.875العائد الربحي
0.04 %السنة الحالية
العام الماضي
الربع الحالي
الربع الأخير
السنة الحالية
العام الماضي
الربع الحالي
الربع الأخير
الشخصيات الرئيسية PPLPHARMA
تحليلات الأرباح PPLPHARMA
نمو الأرباح على مدى 5 سنوات
–النمو المستمر
–معدل الدفع 5 سنوات في المتوسط
–تاريخ الأرباح PPLPHARMA
تقييم الأسهم PPLPHARMA
المالية PPLPHARMA
نتائج | 2019 | ديناميات |